Related Experiment Video
Updated: Jul 10, 2026

14:25
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Published on: May 20, 2014
[Ovarian steroid cell tumor, not otherwise specified: a clinicopathologic study]
1Department of Pathology, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|November 6, 2007
Summary
Ovarian steroid cell tumors, not otherwise specified (NOS), are typically benign. Immunohistochemistry aids diagnosis, and treatment for ovarian steroid cell tumors (NOS) depends on malignancy.
Area of Science:
- Gynecologic pathology
- Endocrinology
- Oncology
Context:
- Ovarian steroid cell tumors, not otherwise specified (NOS), are rare neoplasms.
- Understanding their clinicopathologic features is crucial for accurate diagnosis and management.
Purpose:
- To elucidate the clinicopathologic characteristics, diagnostic criteria, differential diagnoses, and treatment strategies for ovarian steroid cell tumor, NOS.
- To highlight the role of immunohistochemistry in diagnosing these tumors.
Summary:
- This study analyzed 8 cases of ovarian steroid cell tumor, NOS, using light microscopy and immunohistochemistry.
- Seven benign cases showed polygonal cells resembling adrenal gland architecture, while one malignant case exhibited pleomorphism and necrosis. Tumor cells expressed calretinin and alpha-inhibin.
- Differential diagnoses include granulosa cell tumor, thecoma, Sertoli cell tumor, and clear cell carcinoma. Benign tumors were treated with local excision or salpingo-oophorectomy; malignant tumors required surgery and chemotherapy, including GnRH agonist therapy.
Impact:
- Establishes ovarian steroid cell tumor, NOS, as the most common type of ovarian steroid cell tumors, predominantly with benign outcomes.
- Emphasizes immunohistochemistry as a key diagnostic tool for ovarian steroid cell tumors (NOS).
- Provides guidance on treatment selection based on the malignant potential of ovarian steroid cell tumor, NOS.

